The PROPEL™ mometasone furoate family of implants
Connect with us
The PROPEL family of implants release mometasone furoate and have been shown to reduce inflammation and scarring leading to a reduction in the need for postoperative surgical and/or oral steroid interventions.1-3
Reimbursement guide: Non-facility setting
A guide to important coding and billing information in the non-facility setting (ie, physicians office)
Non-facility setting (physician office - place of service 11)
Reimbursement guide: Facility setting
A guide to important coding and billing information in the facility setting (ie, hospital outpatient, and ambulatory surgery center)
Facility setting (hospital outpatient [POS 19/22] and ambulatory surgery center [POS 24])
PROPEL™ payer coverage card
A quick guide to the payers that have positive coverage for PROPEL.
Contact us
The PROPEL sinus implants are intended to maintain patency and locally deliver steroid to the sinus mucosa in patients ≥18 years of age following sinus surgery: PROPEL for the ethmoid sinus, PROPEL Mini for the ethmoid sinus/frontal sinus opening, and PROPEL Contour for the frontal/maxillary sinus ostia. Contraindications include patients with confirmed hypersensitivity or intolerance to mometasone furoate (MF) or hypersensitivity to bioabsorbable polymers. Safety and effectiveness of the implant in pregnant or nursing females have not been studied. Risks may include, but are not limited to, pain/ pressure, displacement of the implant, possible side effects of intranasal MF, sinusitis, epistaxis, and infection.
See full prescribing information (IFU).
Rx only.
Instructions For Use
PROPEL™: US | EU | Patient Implant Information Leaflet (EU)
PROPEL™ Mini: US | EU | Patient Implant Information Leaflet (EU)
PROPEL™ Mini with SDS: US
PROPEL™ Contour: US | EU
Medtronic provides this information for your convenience only. It does not constitute legal advice or a recommendation regarding clinical practice. Information provided is gathered from third-party sources and is subject to change without notice due to frequently changing laws, rules and regulations. The provider has the responsibility to determine medical necessity and to submit appropriate codes and charges for care provided. Medtronic makes no guarantee that the use of this information will prevent differences of opinion or disputes with Medicare or other payers as to the correct form of billing or the amount that will be paid to providers of service. Please contact your Medicare contractor, other payers, reimbursement specialists and/or legal counsel for interpretation of coding, coverage and payment policies. This document provides assistance for FDA approved or cleared indications. Where reimbursement is sought for use of a product that may be inconsistent with, or not expressly specified in, the FDA cleared or approved labeling (e.g., instructions for use, operator’s manual or package insert), consult with your billing advisors or payers on handling such billing issues. Some payers may have policies that make it inappropriate to submit claims for such items or related service.